Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
1Department of Biomedical Sciences, Cihan University-Erbil, Erbil, Kurdistan Region 44001, Iraq
2Department of Clinical Analysis, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan Region 44001, Iraq
3Department of Pharmaceutical Basic Science, Faculty of Pharmacy, Tishk International University, Erbil, Kurdistan Region 44001, Iraq
4Medical Laboratory Science, Lebanese French University, Erbil, Kurdistan Region 44001, Iraq
5Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Kurdistan Region 44001, Iraq
6Department of Medical Laboratory Science, Komar University of Science and Technology, Sulaymaniyah 46001, Iraq
7Department of Medical Microbiology, College of Health Sciences, Hawler Medical University, Erbil, Kurdistan Region 44001, Iraq
8Department of Biology, College of Science, Salahaddin University-Erbil, Erbil, Kurdistan Region 44001, Iraq
9Center of Research and Strategic Studies, Lebanese French University, Erbil 44001, Iraq
10Institute of Human Genetics, Jena University Hospital, 07747 Jena, Germany
11Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 374-37515, Iran
12Department of Clinical Sciences, Malmö, Section for Surgery, Lund University, 22100 Malmö, Sweden
13Translational Neuro-Oncology Laboratory, San Diego (UCSD) Moores Cancer Center, University of California, San Diego, CA 94720, USA
14Faculty of Biology, Institute of Zoology and Biomedical Research, Jagiellonian University, 31-007 Kraków, Poland
15Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran 374-37515, Iran
收起